Lauren Lempert, JD, MPH

Title(s)Specialist, Social Behavioral Sciences
SchoolSchool of Nursing
Address490 Illinois Street, #363
San Francisco CA 94158
Phone510-507-1947
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UC Berkeley School of Public Health, Berkeley, CAMPH05/2006Health Policy & Management
    George Washington Univ. Law School, Washington, DCJD05/1982Law
    Duke University, Durham, NCBA05/1978Philosophy

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vuse Solo e-cigarettes do not provide net benefits to public health: a scientific analysis of FDA's marketing authorisation. Tob Control. 2024 Mar 19; 33(e1):e108-e115. Glantz S, Lempert LK. PMID: 36764683; PMCID: PMC10409877.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    2. A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol. BMC Psychiatry. 2024 Mar 12; 24(1):201. Bold KW, Sharma A, Haeny A, Gueorguieva R, Buta E, Baldassarri S, Lempert L, Krishnan-Sarin S, O'Malley S. PMID: 38475757; PMCID: PMC10935798.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. TAAT and the rise of hemp cigarettes. Tob Control. 2023 Jul 07. Lempert LK. PMID: 37419680.
      View in: PubMed   Mentions:    Fields:    
    4. Impacts of Tax and Flavor Tobacco Policies on San Francisco Bay Area Tobacco Prices. Eval Rev. 2023 10; 47(5):763-785. Pravosud V, Holmes LM, Lempert LK, Ling PM. PMID: 36943027; PMCID: PMC10542911.
      View in: PubMed   Mentions:    Fields:    
    5. Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults. Addict Behav. 2023 05; 140:107632. Gaiha SM, Lin C, Lempert LK, Halpern-Felsher B. PMID: 36731224.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    6. Policies restricting flavors and non-cigarette tobacco product availability: A study of vape shops in San Francisco and Alameda Counties, California, USA. Prev Med Rep. 2022 Dec; 30:101997. Pravosud V, Holmes LM, Lempert LK, Ling PM. PMID: 36176588; PMCID: PMC9512832.
      View in: PubMed   Mentions: 2  
    7. Adolescents, Young Adults, and Adults Continue to Use E-Cigarette Devices and Flavors Two Years after FDA Discretionary Enforcement. Int J Environ Res Public Health. 2022 07 18; 19(14). McCauley DM, Gaiha SM, Lempert LK, Halpern-Felsher B. PMID: 35886599; PMCID: PMC9322506.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Use Patterns, Flavors, Brands, and Ingredients of Nonnicotine e-Cigarettes Among Adolescents, Young Adults, and Adults in the United States. JAMA Netw Open. 2022 05 02; 5(5):e2216194. Gaiha SM, Lin C, Lempert LK, Halpern-Felsher B. PMID: 35612852; PMCID: PMC9133942.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. Flavored Tobacco Sales Restrictions Reduce Tobacco Product Availability and Retailer Advertising. Int J Environ Res Public Health. 2022 03 15; 19(6). Holmes LM, Lempert LK, Ling PM. PMID: 35329145; PMCID: PMC8953832.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. E-cigarette devices, brands, and flavors attract youth: Informing FDA's policies and priorities to close critical gaps. Addict Behav. 2022 03; 126:107179. Gaiha SM, Lempert LK, McKelvey K, Halpern-Felsher B. PMID: 34861522; PMCID: PMC8712419.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    11. Emerging Indoor Air Laws for Onsite Cannabis Consumption Businesses in the U.S. Am J Prev Med. 2021 12; 61(6):e267-e278. Rotering TL, Lempert LK, Glantz SA. PMID: 34400035.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    12. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model. Tob Control. 2022 08; 31(e1):e83-e87. Lempert LK, Bialous S, Glantz S. PMID: 33811155; PMCID: PMC8486889.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2027572. Gaiha SM, Lempert LK, Halpern-Felsher B. PMID: 33270127; PMCID: PMC7716191.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCellsPHPublic Health
    14. Analysis of FDA's IQOS marketing authorisation and its policy impacts. Tob Control. 2020 Jun 29. Lempert LK, Glantz S. PMID: 32601147; PMCID: PMC7952009.
      View in: PubMed   Mentions: 18     Fields:    
    15. Tobacco Industry Promotional Strategies Targeting American Indians/Alaska Natives and Exploiting Tribal Sovereignty. Nicotine Tob Res. 2019 Jun 21; 21(7):940-948. Lempert LK, Glantz SA. PMID: 29546392; PMCID: PMC6588391.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    16. Heated tobacco product regulation under US law and the FCTC. Tob Control. 2018 11; 27(Suppl 1):s118-s125. Lempert LK, Glantz SA. PMID: 30291201; PMCID: PMC6204223.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    17. Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims. Tob Control. 2018 11; 27(Suppl 1):s87-s95. Popova L, Lempert LK, Glantz SA. PMID: 30209208; PMCID: PMC6202239.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    18. IQOS labelling will mislead consumers. Tob Control. 2018 11; 27(Suppl 1):s48-s54. McKelvey K, Popova L, Kim M, Lempert LK, Chaffee BW, Vijayaraghavan M, Ling P, Halpern-Felsher B. PMID: 30158208; PMCID: PMC6252493.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    19. Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA. J Health Polit Policy Law. 2017 08; 42(4):607-644. Carpenter D, Connolly GN, Lempert LK. PMID: 27864349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Letter by Lempert et al Regarding Article, "Menthol and Nonmenthol Cigarette Smoking: All-Cause Deaths, Cardiovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites". Circulation. 2016 Aug 30; 134(9):e119-20. Lempert LK, Yerger V, Glantz SA. PMID: 27572884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Packaging colour research by tobacco companies: the pack as a product characteristic. Tob Control. 2017 05; 26(3):307-315. Lempert LK, Glantz S. PMID: 27255118; PMCID: PMC5135621.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    22. Implications of Tobacco Industry Research on Packaging Colors for Designing Health Warning Labels. Nicotine Tob Res. 2016 09; 18(9):1910-4. Lempert LK, Glantz SA. PMID: 27146637; PMCID: PMC4978986.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    23. The importance of product definitions in US e-cigarette laws and regulations. Tob Control. 2016 Apr; 25(e1):e44-51. Lempert LK, Grana R, Glantz SA. PMID: 25512432; PMCID: PMC4466213.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    24. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation. Tob Control. 2015 Sep; 24(5):469-80. Velicer C, Lempert LK, Glantz S. PMID: 24920577; PMCID: PMC4263698.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Lauren's Networks
    Concepts (62)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.